Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
This study is currently recruiting participants.
Verified October 2012 by University of California, Irvine
Sponsor:
University of California, Irvine
Collaborator:
Pfizer
Information provided by (Responsible Party):
Chao Family Comprehensive Cancer Center, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT01321437
First received: March 21, 2011
Last updated: October 26, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2017 |
| Estimated Primary Completion Date: | December 2017 (Final data collection date for primary outcome measure) |